Company: OSRH
Filing Date: 2025-04-22
Form Type: 10-K
Source: 0001213900-25-034116
Chunk: 892

Company: OSR Holdings, Inc.
Filing Date: 2025-04-22
Form: 10-K
Item: Item 2
Chunk 892
---
, 2024, and extended the date by which the Company
must consummate a business combination to the May 14, 2024. In connection with the extension by which the Company must consummate
a business combination to May 14, 2024, the Company deposited an extension payment of $60,000 into the Trust Account on each
of February 9, 2024, March 12, 2024 and April 9, 2024.

May 2024 Special Meeting

On May 10, 2024,
the Company convened a special meeting of its stockholders as scheduled and adjourned without any business being conducted. The meeting
was reconvened on May 14, 2024 (the “May Special Meeting”). At the May Special Meeting, the Company’s stockholders
approved the proposal to amend the Company’s Charter to extend the date by which the Company must consummate a business combination
from May 14, 2024 to November 14, 2024. Following such approval by the Company’s stockholders, the Company has subsequently
amended the Charter to extend the date by which the Company must consummate a business combination to November 14, 2024. In connection
with the May Special Meeting, 1,581,733 shares of common stock of the Company were tendered for redemption at a redemption price
of approximately $10.78 per share for an aggregate redemption amount of $17,045,763, leaving $20,327,120 in the Trust Account
immediately after the redemptions and a tax withdrawal by the Company of $218,857. Additionally, the Company deposited an extension payment
of $50,000 into the Trust Account on each of May 14, 2024, June 13, 2024, July 12, 2024, August 13, 2024, September 10,
2024, and October 11, 2024.

F-9

OSR HOLDINGS, INC.

(f/k/a Bellevue Life Sciences Acquisition Corp.) 

NOTES TO
CONSOLIDATED FINANCIAL STATEMENTS

DECEMBER 31, 2024

November 2024 Special Meeting

On November
12, 2024, the Company held an annual meeting of its stockholders (the “November Special Meeting”). At the November Special
Meeting, the Company’s stockholders approved two proposals to amend the Company’s Charter